1상모집 중
A Study Understanding How Much CDR132L Enters the Bloodstream After Injection Under the Skin Compared to Injection Into a Vein in Healthy Participants
연구 개요
This study is being done to understand how much of the medicine (CDR132L) enters the bloodstream after injection under the skin compared to injection into a vein in healthy people. This will help us find the best way to give the medicine to people living with heart failure. The study will assess what the body does to the medicine, and how safe it is.
- 스폰서
- 리드: 노보노디스크
- 적응증
- Healthy Volunteers, Heart Failure
- 중재
- CDR132L (i.v.), CDR132L (s.c.)
- 목표 등록
- 32명
- 시작일
- 2026-06-17
- 완료(예정)
- 2026-12-31
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.